CTSD and colorectal cancer: Salinomycin and gefitinib synergistically induce apoptosis via CTSB and CTSD, triggering mitochondrial lysosomal crosstalk and caspase-independent pathways in colorectal cancer cells, and this new combination therapy may provide potential clinical applications to overcome GEF resistance in colorectal cancer 155.